• Connect
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn
  • Subscribe
  • Subscription Link
Arent Fox
  • Firm

    • History

    • Awards & Recognitions

    • Diversity

      • Overview
      • Diversity Scholarship
      • Employees on Diversity
      • LGBT Initiative
      • Women’s Leadership Development Initiative
    • Alumni

    • Pro Bono

      • Overview
      • Current Pro Bono Work
      • Community Involvement
      • Pro Bono Newsletter
      • Pro Bono Awards & Honors
      • FAQ: Pro Bono & Working at Arent Fox
    • Leadership

      • Firm Management
      • Administrative Leadership
  • Deals & Cases

  • People

  • Practices & Industries

    • Practices

      • Advertising, Promotions & Data Security
      • Government Relations
      • Antitrust & Competition Law
      • Health Care
      • Appellate
      • Insurance & Reinsurance
      • Bankruptcy & Financial Restructuring
      • Intellectual Property
      • Commercial Litigation
      • International Trade
      • Communications, Technology & Mobile
      • Labor & Employment
      • Construction
      • Municipal & Project Finance
      • Consumer Product Safety
      • OSHA
      • Corporate & Securities
      • Political Law
      • ERISA
      • Real Estate
      • Environmental
      • Tax
      • FDA Practice (Food & Drug)
      • Wealth Planning & Management
      • Finance
      • White Collar & Investigations
      • Government Contractor Services
    • Industries

      • Automotive
      • Energy Law & Policy
      • Fashion, Luxury Goods & Retail
      • Government Real Estate & Public Buildings
      • Hospitality
      • Life Sciences
      • Long Term Care & Senior Living
      • Media & Entertainment
      • Medical Devices
      • Nonprofit
      • Sports
  • Newsroom

    • Alerts

    • Events

    • Media Mentions

    • Press Releases

    • Social Media

    • Subscribe

  • Careers

    • Lawyers

    • Law Students

    • Professional Staff

  • Contact

    • Washington, DC

    • New York, NY

    • Los Angeles, CA

    Alerts

    • Newsroom Overview
      • Alerts

        Alerts by Criteria

        E.g., 1 / 21 / 2013
        E.g., 1 / 21 / 2013
      • Events
      • Media Mentions
      • Press Releases
      • Social Media
      • Subscribe

    You are here

    Home » Newsroom » Alerts

    Share

    • Printer-friendly version
    • Send by email
    • A Title
    • A Title
    • A Title
    • A
    • A
    • A

    DEA Regulations Allow Retail Pharmacy Installation of Automated Dispensing Systems at Long Term Care Facilities

    June 15, 2005
    As of June 13, 2005, the Drug Enforcement Administration (DEA) will now allow retail pharmacies to install automated dispensing systems at long term care facilities to dispense controlled substances.

    Under previous DEA rules, a retail pharmacy had to dispense a patient's entire prescription to his or her long term care facility. The facility would then have to maintain the drugs and ensure that the patient ingested them as prescribed. If a patient left the facility or the patient's medication changed, the facility was required to retain the excess drugs. Because such facilities were typically not registered with the DEA, they could not transfer the drugs and, instead, had to dispose of them.

    Under the new regulations, retail provider pharmacies now have the option, after registering, of storing controlled substances in an automated dispensing system - a type of vending machine - that dispenses single doses of controlled substances. Because the pharmacy owns the drugs until they are physically dispensed from the machine, any excess can be dispensed to other patients, thereby reducing drug waste and providing substantial cost savings. In addition, because the system electronically records each dispensed controlled substance, pharmacies can assist DEA in investigating any controlled substance diversions.

    Further, and subject to each state's discretion, nurses can now have access to an emergency supply of controlled substances prior to a physician's communication of a prescription to the pharmacy. However, DEA is requiring the states to adopt procedures to ensure that such emergency uses do not undermine the very purpose of the new regulations, which is to reduce illegal diversion and improve overall security.

     

    For questions regarding new regulations - or any DEA-related matters - please contact: 

    Wayne Matelski
    202-857-6340
    matelski.wayne@arentfox.com

    Related People

    • Wayne H. Matelski

    Related Practices

    FDA Practice (Food & Drug)
    Health Care

    Related Industries

    Long Term Care & Senior Living
    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Contact

    Footer Main

    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Subscribe
    • Alumni
    • Diversity
    • Legal Notice
    • Privacy Policy
    • Social Media Disclaimer
    • Nondiscrimination
    • Site Map
    • Client/Staff Login

    Offices

    • Washington, DC
      1717 K Street, NW
      Washington, DC 20036
      Tel: 202.857.6000
    • New York, NY
      1675 Broadway
      New York, New York 10019
      Tel: 212.484.3900
    • Los Angeles, CA
      555 West Fifth Street, 48th Floor
      Los Angeles, California 90013
      Tel: 213.629.7400
    • © Copyright 2013 Arent Fox LLP. All Rights Reserved.

      Legal Disclaimer
      Contents may contain attorney advertising under the laws of some states. Prior results do not guarantee a similar outcome.